ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RPRX Royalty Pharma PLC

27.70
0.00 (0.00%)
01 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Royalty Pharma PLC RPRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 27.70 09:00:00
개장가 저가 고가 종가 전일 종가
27.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/04/202421:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
17/04/202421:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
29/02/202406:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
15/02/202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202421:33EDGAR2Form 8-K - Current report
15/02/202421:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
06/02/202421:01EDGAR2Form 8-K - Current report
31/01/202406:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
19/01/202422:15GLOBERoyalty Pharma Announces Dividend Increase
08/01/202421:18EDGAR2Form 8-K - Current report
08/01/202421:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
04/01/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:30EDGAR2Form 144 - Report of proposed sale of securities
30/12/202306:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202306:31EDGAR2Form 8-K - Current report
28/12/202303:05EDGAR2Form 8-K - Current report
20/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:47EDGAR2Form 144 - Report of proposed sale of securities
28/11/202306:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
17/11/202307:16EDGAR2Form 8-K - Current report
17/11/202307:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/11/202309:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
13/11/202322:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
08/11/202323:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:40EDGAR2Form 8-K - Current report
08/11/202321:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
19/10/202322:29EDGAR2Form 8-K - Current report
19/10/202320:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
17/10/202305:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend
12/10/202305:15GLOBERoyalty Pharma To Announce Third Quarter 2023 Financial..
04/10/202305:15EDGAR2Form 144 - Report of proposed sale of securities
04/10/202305:15EDGAR2Form 144 - Report of proposed sale of securities
21/09/202321:25GLOBERoyalty Pharma Appoints Eric Schneider as Chief Technology..
06/09/202305:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
06/09/202305:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
05/09/202321:25GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
24/08/202319:30GLOBERoyalty Pharma and Ferring Pharmaceuticals Enter Into US..
24/08/202314:15BWRoyalty Pharma and Ferring Pharmaceuticals Enter into US..
12/08/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:45EDGAR2Form 144 - Report of proposed sale of securities
09/08/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:31EDGAR2Form 8-K - Current report
08/08/202320:00GLOBERoyalty Pharma Reports Second Quarter 2023 Results
19/07/202305:15GLOBERoyalty Pharma to Announce Second Quarter 2023 Financial..
18/07/202305:15GLOBERoyalty Pharma Declares Third Quarter 2023 Dividend
15/07/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock